Skip to content

Nxthera, Inc.

United StatesFDA applicant, unverified

Devices
5
FDA recalls
1

At a glance

Counted by deviCERTS from registry records

Market reach

United States
FDA recalls

What Nxthera, Inc. makes

Nxthera, Inc. manufactures single-use percutaneous radio-frequency ablation probe cannulas designed for medical procedures. These devices are primarily used in the Rezum System, which employs radio-frequency energy to treat benign prostatic hyperplasia (BPH).

The company’s products fall under FDA Class II regulation and are listed in the FDA’s 510(k) and UDI registries. Nxthera, Inc. is based in the United States.

AI-generated from registry data, 26 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue5

Newest first, rows 1-5 of 5

  • rezum D2201

    None Registry: GUDID Class:II
  • Rezūm Accessory Kit D2202

    Withdrawn Registry: GUDID Class:II
  • Rezum System Ref K150786

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Rezum System Ref K180237

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Rezum System Ref K160417

    Active Regimes: 510(k) Registry: 510(k) Class:II

Company details

DUNS number
947824194
Phone
6123969849

FDA recalls1

Recalls are matched to the firm by name. FDA recall data as of 22 Oct 2026.

FDA recall records list 1 recall initiated by Nxthera, Inc., initiated on 2017-07-28. By recorded status: 1 terminated. The reasons filed fall into these groups: other reasons as filed. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.

Generated automatically from FDA recall records, as a summary of the records listed below. It describes what the records state and is not an assessment of this manufacturer.

Recalls initiated per year

  • 2017 1
  • 2018 0
  • 2019 0
  • 2020 0
  • 2021 0
  • 2022 0
  • 2023 0
  • 2024 0
  • 2025 0
  • 2026 0
  • 2017

    • 28 Jul 2017 Z-0262-2018 Class II Terminated Needle Bond may not be able to withstand the tension force applied when the shaped needle is deployed into and retracted from prostate tissue to deliver treatments. Distribution: USA Distribution to the states of : AL, AZ, CA, CO, FL, GA, IL, MA, MI, MN, MO, NE, NJ, NY, OH, PA, TN, UT, WA. Submission number: K160417

Frequently asked questions

How many devices does Nxthera, Inc. have in the registry?

The registry currently lists 5 devices for Nxthera, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Nxthera, Inc.'s devices?

Among its 5 most recently registered devices, Nxthera, Inc. has devices listed in FDA 510(k) (3 devices) and FDA GUDID (2 devices). A device can be listed in more than one registry, so these counts overlap.

What risk classes do Nxthera, Inc.'s devices fall under?

Among its 5 most recently registered devices, the classes recorded for Nxthera, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

Are there FDA recall records for Nxthera, Inc.?

FDA recall records list 1 recall initiated by Nxthera, Inc., the most recent initiated on 28 Jul 2017. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What are the newest devices from Nxthera, Inc. in the registry?

The most recently registered devices listed for Nxthera, Inc. include rezum D2201, Rezūm Accessory Kit D2202 and Rezum System.

Generated automatically from registry data and not verified by a human reviewer.